376
Participants
Start Date
March 1, 2021
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Stereotactic body radiotherapy
All patients accrued will be treated with SBRT to all sites of active metastatic disease as per CT scan or PET/CT and/or MRI. A range of schedules and doses are provided, it is advised that the maximum dose that can be achieved whilst meeting the organs at risk planning constraints is prescribed.
Ospedale Vito Fazzi, Lecce
Responsible Research Hospital, Campobasso
S.C. di Radioterapia Oncologica-Azienda Sanitaria locale, Biella
"Azienda Ospedaliera Cannizzaro", Catania
Azienda sanitaria locale Lanciano Vasto Chieti, Chieti
Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute, Milan
Humanitas Clinical and Research Center-IRCCS, Milan
Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia
Fatebenefratelli Isola Tiberina-Gemelli Isola,, Roma
S Maria Hospital, Terni
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - SOC Radioterapia, Udine
Campus Biomedico, Roma
Policlinico A. Gemelli, IRCCS, Roma
Università La Sapienza, Roma
Fondazione Policlinico Universitario A. Gemelli, IRCCS
UNKNOWN
Gemelli Molise Hospital
OTHER